AI Framework for Enterprise Data Analysis and Client Insights
The USPTO has published a patent application for an AI framework designed to analyze enterprise data, including employee-client communications, to provide insights and recommendations. The framework incorporates machine learning models and adheres to enterprise data sharing and access control requirements.
AI Models for Detecting and Mitigating Ambiguity in Natural Language Text
The USPTO has published a patent application (US20260087260A1) detailing methods for using AI models to detect and mitigate ambiguity in natural language text. The application describes systems that can identify ambiguous text, provide alternative interpretations, and generate responses based on user selection.
CHFS Office of Public Affairs Contact Information and News Releases
The Cabinet for Health and Family Services (CHFS) Office of Public Affairs has updated its contact information for media inquiries and general public information. The notice provides direct contact details for the Executive Director and Deputy Executive Director, along with the agency's mailing address and a link to request speakers.
WHO Member States Extend Pandemic Agreement PABS Annex Talks
WHO Member States have agreed to extend negotiations on the Pathogen Access and Benefit Sharing (PABS) annex to the WHO Pandemic Agreement. Discussions will resume in late April and early May 2026, ahead of consideration by the World Health Assembly.
Exchange Coverage Remains Near Record High with 23.1 Million Enrolled in 2026
The Centers for Medicare & Medicaid Services (CMS) reported that 23.1 million consumers selected or were automatically re-enrolled in coverage through the Health Insurance Exchanges for plan year 2026. The report highlights the impact of CMS enforcement actions to prevent fraud, which resulted in the removal of nearly 1.5 million improper enrollments.
Dr. George A. Csank Voluntarily Resigns Massachusetts Medical License
Dr. George A. Csank, M.D. voluntarily resigned his Massachusetts medical license pursuant to 243 CMR 1.05(5)(a), signing the resignation under oath on January 30, 2026. The resignation is acknowledged as a disciplinary action that will be reported to the National Practitioner Data Bank and the Federation of State Medical Boards. The action is final and not subject to reconsideration or judicial review.
BIOLITEC Trademark Registration for Medical and Surgical Optical Fibers and Lasers
The USPTO has registered the trademark 'BIOLITEC' for custom manufacturing of optical fibers, lasers, and related accessories for medical and surgical use. The registration was finalized on March 26, 2026, following a filing date of February 21, 2001.
USPTO Trademark Registration for Medical Devices
The USPTO has registered trademark application TM77410879 for an implantable medication pump, catheters, and related accessories. The registration was finalized on March 26, 2026, based on a filing date of March 3, 2008.
Measles Virus Detected in Wastewater; Preventive Advisory Issued
The New Jersey Department of Health issued a preventive advisory after detecting the measles virus in wastewater samples collected on March 20, 2026, in Essex County. While a subsequent sample on March 23 was negative and no clinical cases have been identified, the detection indicates the presence of measles in the community. Residents are urged to ensure they are up-to-date on MMR vaccinations, especially those traveling internationally.
Measles Virus Detected in Wastewater, Advisory Issued
The New Jersey Department of Health issued an advisory after measles virus was detected in a wastewater sample from Essex County. While a subsequent sample was negative and no clinical cases have been identified, the detection serves as an early warning for potential community presence of the virus. Residents are urged to ensure they are up-to-date on their MMR vaccinations.
National Institute on Minority Health and Health Disparities; Notice of Partially Closed Meeting
The Department of Health and Human Services, through the National Institutes of Health, has issued a notice regarding a partially closed meeting of the National Institute on Minority Health and Health Disparities. The meeting is scheduled for May 19, 2026.
Center for Scientific Review; Notice of Closed Meetings
The National Institutes of Health, through the Center for Scientific Review, has issued a notice announcing upcoming closed meetings. These meetings are part of the review process for grant applications and are scheduled to occur on April 22, 2026.
Proposed Data Collection for National Child Abuse and Neglect Data System
The Administration for Children and Families (ACF) is proposing a new data collection activity for the National Child Abuse and Neglect Data System. This notice is open for public comment until May 29, 2026.
Proposed Information Collection Activity for AFCARS System
The Administration for Children and Families (ACF) is proposing a new information collection activity for the Adoption and Foster Care Analysis and Reporting System (AFCARS). This notice is open for public comment until May 29, 2026.
Endo Optimized Trademark Application for Medical Instruments
The USPTO has received a trademark application for the mark 'Endo Optimized' filed on July 9, 2024. The application covers a range of medical instruments and educational services related to dental treatment procedures, particularly root canals.
Trademark Registered for Medical Lasers and Instruments
The USPTO has registered a trademark (TM79420495) for 'THERMOLIPOLISIS' covering lasers for medical purposes, medical apparatus and instruments, and esthetic massage apparatus. The registration was finalized on March 26, 2026.
Microporator Trademark Registered for Medical Instruments and Cell Therapy
The USPTO has registered the trademark 'Microporator' for a range of medical instruments and cell therapy apparatus. The registration covers scientific and laboratory equipment for cell modification, analysis, and culture, as well as medical devices for immunotherapy and regenerative medicine.
USPTO Trademark Registration for SLEEPGYM
The USPTO has published a trademark application for SLEEPGYM, which includes goods such as therapeutic mouth tapes, breathing apparatus, and sleep aid accessories. The application was published for opposition on March 26, 2026, with a filing date of July 30, 2025.
SYREX Medical Instrument Trademark Application Published
The USPTO has published the trademark application for SYREX, a medical instrument. The application, filed on December 20, 2024, covers surgical and medical apparatus, appliances, and instruments for use in the radiology, cardiology, and neurology sectors. Publication occurred on March 26, 2026, initiating a period for opposition.
ECORE Medical Devices Trademark Application
The USPTO has published a trademark application for 'ECORE' filed by a medical device company. The application covers devices for blocking blood flow, preventing embolization reflux, and use in endovascular and embolization procedures.
Mabxience Trademark Application for Medical Instruments and Pharmaceuticals
The USPTO has published a trademark application (TM79414585) for Mabxience, covering pharmaceutical preparations for various diseases and medical/surgical instruments. The application was filed on December 17, 2024, and published for opposition on March 26, 2026.
BIOLITEC BIOMEDICAL TECHNOLOGY Trademark Registration
The USPTO has registered the trademark 'BIOLITEC BIOMEDICAL TECHNOLOGY' for medical lasers, optical fibers, and related accessories. The registration covers goods and services including lasers, light sources, lenses, catheters, and topical preparations for medical and surgical use.
KLS MARTIN Registered Trademark for Surgical Implants and Instruments
The USPTO has registered the trademark TM78650586 for KLS MARTIN, covering oral, maxillofacial, and cranial surgical implants, as well as surgical instruments. The trademark was registered on March 26, 2026, following a filing date of June 14, 2005.
Guldmann USPTO Trademark for Medical Lifting Equipment
The USPTO has published a trademark application for Guldmann, a company specializing in medical lifting equipment. The application covers a range of products and services related to patient mobility and healthcare assistance, including hoists, slings, and related services.
Trademark Registration: Protective Gloves and Masks for Medicine and Dentistry
The USPTO has registered trademark application TM79391698 for protective gloves and masks used in medicine and dentistry. The registration was finalized on March 26, 2026, following a filing date of January 26, 2024. This action pertains to intellectual property rights for specific medical and dental protective equipment.
Trademark Registration: SLOW PLEASURE TECHNOLOGY
The USPTO has registered the trademark 'SLOW PLEASURE TECHNOLOGY' (TM79424343) for goods including sex aids, sex toys, vibrators, pharmaceutical preparations, medical preparations, and spermicidal creams. The registration was finalized on March 26, 2026, following a filing date of February 12, 2025.
USPTO Trademark Registration for EO ENDO. OPTIMIZED. Medical Instruments
The USPTO has issued a trademark registration for the mark 'EO ENDO. OPTIMIZED.' for medical instruments, including those for dental root canal treatment. The registration covers a range of dental and medical devices, as well as related educational materials and services.
FDA Guidance on Incorporating Patient Preference Information
The Food and Drug Administration (FDA) has issued a notice announcing the availability of its final guidance on incorporating voluntary patient preference information throughout the total product life cycle. This guidance is intended for industry, FDA staff, and other interested parties.
USPTO Publishes VENTORA Medical Instrument Trademark Application
The USPTO has published the trademark application for 'VENTORA', a brand associated with medical instruments and monitoring devices. The application, filed on July 31, 2025, covers a range of products including software for physiological data analysis, respiratory monitors, and enteral feeding equipment. Publication opens a period for potential opposition to the trademark.
Smart horseshoe health monitoring devices, sensors, medical analysis
Smart horseshoe health monitoring devices, sensors, medical analysis
ANI CARD Trademark for Medical and Veterinary Instruments
The USPTO has published the trademark application for 'ANI CARD' for goods and services including medical and veterinary instruments, scientific laboratory services, and agricultural testing. The application was filed on May 17, 2024, and published for opposition on March 26, 2026.
M.A.R.I.O trademark for surgical devices and instruments
The USPTO has published the trademark application for 'M.A.R.I.O' for use with surgical devices and instruments. The application was published for opposition on March 26, 2026, following a filing date of February 12, 2025.
PRAM Trademark for Medical Diagnostic Instruments and Software
The USPTO has published the trademark application for 'PRAM' for use with medical diagnostic instruments, software, and related diagnostic services. The application was published for opposition on March 26, 2026, following a filing date of March 7, 2025.
SPINAFX trademark published for medical devices
The USPTO has published the SPINAFX trademark application for opposition. The application covers various medical devices, including ozone injection systems, syringe cartridges, ozone generators, and measuring units for medical use.
MELIOONE Trademark Application for Medical Devices
The USPTO has published a trademark application for the mark 'MELIOONE' filed by an unnamed applicant. The application covers medical devices, including pain relief medication and intrauterine devices, with a filing date of September 18, 2025.
XPRF Medical and Veterinary Instruments Trademark Application
The USPTO has published a trademark application for 'XPRF' by an unnamed applicant. The application covers medical and veterinary instruments, including blood collecting tubules, centrifuges, and treatment kits. The filing date was July 14, 2025.
JOINFIX Trademark Application for Surgical Instruments
The USPTO has published the trademark application for 'JOINFIX', intended for use with surgical instruments and various medical devices. The application was filed on November 5, 2025, and published for opposition on March 26, 2026.
FUSIONLOC surgical implants trademark published
The USPTO has published the FUSIONLOC trademark application for surgical implants and orthopaedic articles. The application was published for opposition on March 26, 2026, with a filing date of November 5, 2025.
SAFETOUCH CATH AQT Trademark Application Published
The USPTO has published the trademark application for SAFETOUCH CATH AQT, which covers medical instruments and apparatus including medical and surgical catheters and needles for medical use. The application was filed on August 8, 2025, and published for opposition on March 26, 2026.
NICLOVPIC Trademark Application for Medical and Adult Products
The USPTO has published a trademark application for the mark NICLOVPIC, intended for use with various medical and adult products including sex dolls, massage apparatus, and adult sexual stimulation aids. The application was published for opposition on March 26, 2026, with a filing date of March 25, 2026.
KENTIX Trademark Covers Clinical Thermometers and Sensors
The USPTO has published the trademark application for KENTIX, covering a range of scientific and electrical apparatus, including clinical thermometers and temperature sensors for medical and commercial use. The application was filed on November 15, 2024, and published for opposition on March 26, 2026.
ONEPAL Trademark for Medical Shipping Containers
The USPTO has published the trademark application for 'ONEPAL', covering temperature-controlled medical shipping containers and related wholesale/retail services. The application was published for opposition on March 26, 2026, following a filing date of February 25, 2025.
USPTO Trademark Application for Medical, Surgical, Dental Apparatus
The USPTO has published a trademark application (TM79421036) covering a broad range of goods and services, including medical, surgical, and dental apparatus, as well as pharmaceuticals and food products. The application was filed on December 25, 2024.
NODICA Trademark Published for Opposition
The USPTO has published the trademark application for 'NODICA' for opposition. The application covers a wide range of goods and services, including data processing, retail services for electrical apparatus, and specifically mentions magnetic resonance imaging (MRI) apparatus and linear accelerators for medical use.
CIRQ ZERO-G Trademark Application - Medical Instruments and Devices
The USPTO has published the trademark application for 'CIRQ ZERO-G', which includes goods and services related to medical instruments, devices, and robotic systems. The application covers software for controlling robotic devices, educational seminars, and various medical apparatus.
MOBITOOLS Trademark Application Published
The USPTO has published the trademark application for MOBITOOLS, which covers patient safety restraints and orthopedic devices. The application was published for opposition on March 26, 2026, with a filing date of March 11, 2025.
M MYAH Trademark Application - Ophthalmic Therapeutic and Testing Apparatus
The USPTO has published a trademark application for 'M MYAH' (TM79432399) for ophthalmic therapeutic and testing apparatus. The application was filed on July 16, 2025, and published for opposition on March 26, 2026. This is a routine trademark filing and does not impose new regulatory obligations.
Ophthalmic Therapeutic Apparatus and Eye Testing Devices Trademark
The USPTO has published a trademark application (TM79432561) for ophthalmic therapeutic apparatus, eye testing devices, keratoscopes, and axial length measuring devices. The application was filed on July 16, 2025, and published for opposition on March 26, 2026.
Advisory Board on Radiation and Worker Health Meeting Notice
The Centers for Disease Control and Prevention (CDC) has issued a notice announcing a meeting of the Advisory Board on Radiation and Worker Health. The meeting is scheduled for March 30, 2026, and the public comment period for this notice closes on April 15, 2026.
Advisory Board on Radiation and Worker Health Meeting Notice
The Centers for Disease Control and Prevention announced a meeting of the Advisory Board on Radiation and Worker Health, Subcommittee for Procedure Reviews. The meeting is scheduled for June 5, 2026, and will focus on procedure reviews.
USP Granted Patent for Automated NMR System
The U.S. Pharmacopeia (USP) has been granted a patent by the United States Patent and Trademark Office for an automated nuclear magnetic resonance (NMR) system. This patented approach aims to make NMR technology more reliable and easier to use by automating spectral processing and comparison to USP reference standards.
USP Dietary Supplement Program Recognized by Amazon's Compliance Fast-Track Program
The U.S. Pharmacopeia (USP) has been named a participating certifier in Amazon's new Compliance Fast-Track Program for dietary supplements. This recognition means products bearing the USP Verified Mark will be automatically accepted by Amazon, streamlining market access for compliant manufacturers.
USP Develops Digital Quality Standards for Workflows
The U.S. Pharmacopeia (USP) announced the development of digital reference standards (dRS) and digitally structured compendial methods (dDS) to integrate quality standards into digital workflows. This initiative aims to enhance consistency, reduce risk, and strengthen regulatory confidence for manufacturers adopting digital technologies in drug development and manufacturing.
Fugitive Wanted for Cocaine Conspiracy
The DEA is seeking the public's assistance in locating Abraham Vivanco Leon, a fugitive wanted for conspiracy to distribute and possess with intent to distribute cocaine. Information and tips can be submitted through the DEA website and to the U.S. Marshals Service.
Iowa Methamphetamine Seizures Rise
The DEA Omaha Division reported a significant increase in methamphetamine seizures in Iowa, with 250 pounds confiscated in less than four months. The notice encourages the public to learn more about the facts surrounding these seizures.
DEA Seizes 900,000 Fentanyl Doses and 500,000 Pills in L.A.
The DEA announced the seizure of 900,000 potentially lethal doses of fentanyl and 500,000 counterfeit pills in Los Angeles. This action, taken in coordination with law enforcement partners, removed a significant quantity of dangerous drugs from circulation.
Healthcare Authority Newsletter - March 2026
The Centers for Medicare & Medicaid Services (CMS) has doubled its nursing home staffing campaign funding to $200 million. The newsletter also highlights state encouragement for ACA signups, physicians forming IPAs, increased healthcare IT and cybersecurity investments, a report urging reform of private equity investment in healthcare, and CMS's efforts to leverage AI for Medicare beneficiaries.
EU Privacy Regulators Issue Opinion on Proposed Biotech Act
The European Data Protection Board (EDPB) and European Data Protection Supervisor (EDPS) issued a joint opinion on the proposed EU Biotech Act. The opinion supports the act's goals but calls for clarification on GDPR compliance, data processing, consent, AI obligations, and data retention for clinical trials involving medicinal products.
CDC Solicitation of Nominations for Mine Safety and Health Research Advisory Committee
The CDC is soliciting nominations for membership on the Mine Safety and Health Research Advisory Committee (MSHRAC). The committee consists of 10 experts in mining safety and health research and practice. Nominations are due by April 22, 2026.
CMS Seeks Letters of Intent for Medicare Lifestyle Intervention Funding
The Centers for Medicare and Medicaid Services (CMS) is seeking letters of intent for the MAHA ELEVATE Model, a new funding opportunity to pilot lifestyle interventions within Original Medicare. Approximately $100 million will be awarded over three years to 30 cooperative agreements, with letters of intent due by April 10, 2026.
FTC Creates Healthcare Task Force
The Federal Trade Commission (FTC) has established an internal Healthcare Task Force to enhance enforcement and policy efforts related to competitive and affordable healthcare. The task force aims to improve knowledge sharing, identify emerging issues like AI in healthcare, and expand inter-agency collaboration.
NCDHHS Secretary Visits Eastern North Carolina
North Carolina Health and Human Services Secretary Dev Sangvai visited eastern North Carolina to discuss Medicaid, SNAP, and the Rural Health Transformation Program. Discussions included the impacts of federal legislation H.R. 1 on the state's Medicaid program, particularly expanded work requirements and eligibility redeterminations.
Mississippi Confirms First Pediatric Flu Death of 2025-2026 Season
The Mississippi State Department of Health (MSDH) has confirmed the first pediatric influenza death in the state for the 2025-2026 flu season. The department encourages vaccination for individuals six months and older and advises on other measures to reduce flu spread.
FDA Complaint Filed and Closed for Comments
The Food and Drug Administration (FDA) has filed a complaint and opened it for public comment. The complaint, filed on March 27, 2026, is available for review and submission of feedback.
FDA Background Material for Docket FDA-2026-P-3242
The Food and Drug Administration (FDA) has posted background material related to docket FDA-2026-P-3242. This material is available for public review and does not impose new regulatory requirements.
FDA Complaint Docket FDA-2026-H-3040
The Food and Drug Administration (FDA) has opened a new complaint docket, FDA-2026-H-3040, related to a complaint filed by CTP. No documents are currently available for viewing or download within this docket.
FDA Complaint Filed for Public Comment
The Food and Drug Administration (FDA) has opened a public comment period for a filed complaint related to its regulations. The complaint, authored by CTP, is available for review and download on regulations.gov. This action initiates a consultation period for interested parties to provide feedback.
FDA Complaint Document
The Food and Drug Administration (FDA) has posted a complaint document to the Federal Docket Management System. The document, authored by CTP, is available for review and download via the provided links.
Preeclampsia Risk and IVF Cycles Guidance
The Food and Drug Administration (FDA) has issued new guidance regarding the risk of preeclampsia associated with in vitro fertilization (IVF) cycles. This guidance aims to inform healthcare providers and patients about potential risks and management strategies.
FDA Complaint Filed and Closed for Comments
The Food and Drug Administration (FDA) has filed a complaint and opened it for public comment. The complaint is related to the Center for Tobacco Products (CTP) and has a filing date of March 27, 2026.
FDA Complaint Document Details
The Food and Drug Administration (FDA) has posted a complaint document related to its regulatory activities. The document is available for review on the regulations.gov portal, with a specific detail date of March 27, 2026. No further details on the nature of the complaint or its implications are provided in the initial posting.
FDA Complaint Document Posted
The Food and Drug Administration (FDA) has posted a complaint document related to its regulatory activities. This document is available for public review and comment, with a specific deadline for submissions.
FDA Document on Uterine Lavage and Live Births
The Food and Drug Administration (FDA) has issued a document concerning uterine lavage and its relation to live births. This notice provides information on the topic, likely for public awareness or to inform stakeholders in the healthcare and pharmaceutical sectors.
Mifepristone Clinical Indications Systematic Review Document
The Food and Drug Administration has issued a systematic review document regarding the clinical indications for mifepristone. This document outlines the FDA's review process and findings related to the drug's approved uses.
FDA Acknowledgement Letter to Steranco Healthcare Pvt. Ltd.
The Food and Drug Administration (FDA) has issued an acknowledgement letter to Steranco Healthcare Pvt. Ltd. The letter confirms receipt of documentation related to a submission. No specific details regarding the nature of the submission or any required actions are provided in the available information.
FDA Final Response
The Food and Drug Administration (FDA) has posted a final response related to docket FDA-2022-P-2644-0046. The document, authored by CDRH, is available via the provided URL and download link.
FDA Complaint Document Closed for Comments
The Food and Drug Administration (FDA) has closed a complaint document for public comments. The document, authored by CTP, is available for download via a link on regulations.gov. No specific details about the complaint's content or its regulatory impact are provided.
PGT-A Using Human In Vivo - Part 1 & 2
FDA's Center for Drug Evaluation and Research (CDER) received a submission titled 'PGT-A using human in vivo - Part 1 & 2' filed on regulations.gov under docket FDA-2026-P-3169-0007. The landing page indicates no documents are currently available to view or download, though two PDF attachments are listed. The submission relates to preimplantation genetic testing for aneuploidy (PGT-A) using human in vivo methodology.
FDA Supporting Material for Proposed Rule
The Food and Drug Administration (FDA) has posted supporting material for a proposed rule on March 27, 2026. This material is associated with docket number FDA-2026-P-3242. The posting provides additional context and data related to the proposed regulatory action.
Citizen Petition from Charlene Peters
The Food and Drug Administration (FDA) has received a citizen petition from Charlene Peters. The petition is currently available for review, with a redacted version provided for public access.
FDA Complaint Document Posted for Comments
The Food and Drug Administration (FDA) has posted a complaint document for public comment, with the comment period closing on March 27, 2026. The document is related to a complaint filed by CTP.
FDA Complaint Document
The Food and Drug Administration (FDA) has posted a complaint document related to its regulatory activities. The document, authored by the Center for Tobacco Products (CTP), is available for review and download via the regulations.gov portal.
FDA Acknowledgement Letter to Charlene Peters
The Food and Drug Administration (FDA) has issued an acknowledgement letter to Charlene Peters regarding a submission. The letter, authored by CDER, confirms receipt of the document. No specific details about the submission's content or regulatory implications are provided.
FDA Complaint Document
The Food and Drug Administration (FDA) has posted a complaint document related to its regulatory activities. The document, authored by CTP, is available for review on Regulations.gov. No specific compliance actions or deadlines are indicated.
Appco Pharma LLC Suitability Petition
The Food and Drug Administration (FDA) has received a suitability petition from Appco Pharma LLC. The petition is related to drug manufacturing and regulatory filings.
FDA Complaint Filed and Closed for Comments
The Food and Drug Administration (FDA) has filed a complaint and opened it for public comment. The complaint, filed on March 27, 2026, is available for review and submission of feedback through the Regs.gov portal.
Proposed Rule to Reduce Native American Program Bureaucracy
The Administration for Children and Families (ACF) proposes to amend Native American Programs Act regulations (45 CFR part 1336) to eliminate unnecessary or obsolete regulations. This proposed rule aims to reduce bureaucracy for Native American programs and impacts States, Territories, and Tribal Lead Agencies.
Proposed Rule: Human Services Repatriation Program Regulations
The Administration for Children and Families (ACF) proposes to amend regulations concerning the care and treatment of mentally ill nationals and assistance for U.S. citizens returned from foreign countries. The proposed rule aims to eliminate unnecessary or obsolete regulations, with a comment deadline of April 27, 2026.
Rescinding Obsolete Provisions of State Legalization Impact Assistance Grants Regulations
The Administration for Children and Families (ACF) is issuing a direct final rule to rescind obsolete provisions of the State Legalization Impact Assistance Grants (SLIAG) regulations (45 CFR part 402). This action aims to reduce regulatory burdens and streamline processes. The rule is effective May 26, 2026, unless significant adverse comments are received by that date.
Measles Outbreak Update: 997 Cases Total, No New Cases Reported
The South Carolina Department of Public Health reported no new measles cases since Tuesday, maintaining the Upstate outbreak total at 997 cases. The department noted that 42 days without new cases are required to declare the outbreak over, with the potential end date set for April 26 if no further cases arise.
LDH Reports Seafood Sampling Results from Oil Spill Area
The Louisiana Department of Health (LDH) has reported initial seafood sampling results from an area affected by an oil leak. Samples of oysters, shrimp, finfish, and crab from Basin 12 showed clear results for petroleum contamination. The LDH previously closed Basin 12 to oyster harvesting as a precautionary measure.
DOH Reports Travel-Related Dengue Virus Case on Oʻahu
The Hawaiʻi Department of Health (DOH) reported a new travel-related dengue virus case on Oʻahu, bringing the state total to four for 2026. While the risk of local transmission is considered low, the DOH is reminding the public to reduce standing water to prevent mosquito breeding.
Kaua'i Health Office Hosts Public Open House for National Public Health Week
The Kaua‘i District Health Office (KDHO) is hosting a public open house on April 10, 2026, to celebrate National Public Health Week. The event will showcase public health services, programs, and career opportunities, encouraging community engagement and awareness.
EMA Recommends Restricting Tecovirimat SIGA for Mpox Treatment
The EMA's Committee for Human Medicines has recommended restricting the use of Tecovirimat SIGA for the treatment of mpox. Clinical trials showed the medicine was not effective in healing lesions faster than placebo in mpox patients with active lesions. This recommendation does not affect other authorised uses of Tecovirimat SIGA.
EMA Recommends Imdylltra for Relapsed Small Cell Lung Cancer
The European Medicines Agency (EMA) has recommended marketing authorisation for Imdylltra (tarlatamab) for adults with relapsed extensive-stage small cell lung cancer. This recommendation is based on Phase 3 trial data showing improved overall survival and progression-free survival compared to standard of care.